Stocks
Dr. Reddy's Laboratories (RDY) EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA, ₹ | ? | 47 743 000 000 | 108 784 000 000 | 74 431 000 000 | 81 049 000 000 | 82 574 000 000 | 85 773 000 000 | ||
| Changes by years, y/y, % | -9% | +128% | -32% | +9% | +2% | +28.5% | |||
Dr. Reddy's Laboratories. EBITDA US GAAP, ₹
Dr. Reddy's Laboratories. EBITDA US GAAP, changes, %
Dr. Reddy's Laboratories. EBITDA US GAAP, sum by quarters, ₹
Dr. Reddy's Laboratories (RDY) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2024Q4 | 2024Q3 | 2025Q1 | 2025Q2 | LTM ? | |||
| EBITDA, ₹ | ? | 18 499 000 000 | 18 499 000 000 | 21 618 000 000 | 21 757 000 000 | 23 899 000 000 | 85 773 000 000 | |
| Changes by years, y/y, % | -26% | -26% | +12% | +23% | +18% | |||
| Changes by quarters, q/q, % | -13% | 0% | +17% | +1% | +10% | |||
